Single-Agent Pembrolizumab Active Against STK11- and KEAP1- Mutated NSCLC According to KEYNOTE-042 Analysis

Impact of COVID-19 on the Diagnostic Workup of Lung Cancer

Systemic Therapy for Advanced Stage Lung Cancer During the COVID-19 Pandemic

Impact of COVID-19 on Treatment of Lung Cancer Patients with Local or Locoregional Disease

Practical Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement

PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee

#LCSM Chat Topic 6/4/2020: #ASCO20 Roundup for #LungCancer

IASLC 2020 World Conference on Lung Cancer Postponed

Tumor Mutation Burden: Evolution of a Controversial Biomarker From the Pathologist’s Perspective

PD-L1 in Cytology Specimens

First-Ever IASLC School of Nursing Held at Latin American Lung Cancer Regional Meeting in Mexico City

Highlights From the 2019 IASLC Latin American Conference in Lung Cancer